The UroVysion fluorescence in situ hybridization assay is an effective tool for monitoring recurrence of bladder cancer

Urologic Oncology: Seminars and Original Investigations

Volumn 22, Issue 1, 2004, Pages 16-19

  Varella Garcia, Marileila ^a,b   Akduman, Bulent ^a,c   Sunpaweravong, Patrapim ^a,d   Di Maria, Michael V ^b   Crawford, E David ^a,b  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF COLORADO CANCER CENTER   (United States)

^c ZONGULDAK KARAELMAS UNIVERSITY   (Turkey)

^d PRINCE OF SONGKLA UNIVERSITY   (Thailand)

Author keywords

Bladder neoplasms; Cystoscopy; Cytogenetic analysis; Cytology; Fluorescence; In situ hybridization; Molecular diagnostic techniques; Neoplasm recurrence; Urine

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER CANCER; BLADDER DIVERTICULUM; CANCER DIAGNOSIS; CANCER RECURRENCE; CHROMOSOME ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTOSCOPY; CYTODIAGNOSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DNA PROBE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; MALE; PATIENT MONITORING; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; TUMOR BIOPSY; URINE CYTOLOGY;

AGED; AGED, 80 AND OVER; CYSTOSCOPY; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MASS SCREENING; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PILOT PROJECTS; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; URINALYSIS; URINARY BLADDER NEOPLASMS;

EID: 2142713040     PISSN: 10781439     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1078-1439(03)00098-X     Document Type: Article

References (14)

1. Ramakumar S., Bhuiyan J., Besse J.A., et al. Comparison of screening methods in the detection of bladder cancer. J Urol. 161:1999;388-394
2. Koenig F., Jung K., Schnorr D., Loening S. Urinary markers of malignancy. Clinica Chimica Acta. 297:2000;191-205
3. Loweshwar V.B., Soloway M.S. Current bladder tumor tests does their projected utility fulfill clinical necessity? J Urol. 165:2001;1067-1077
4. Hackel C., Varella-Garcia M. Interphase cytogenetics using fluorescence in situ hybridization an overview of its application to diffuse and solid tissue. Braz J Genet. 20:1997;97-106
5. Fadl-Elmula I., Gorunova L., Madahl N., et al. Karyotypic characterization of urinary bladder transitional cell carcinomas. Genes Chrom Cancer. 29:2000;256-265
6. Fadl-Elmula I., Kytola S., Pan Y., et al. Characterization of chromosomal abnormalities in urothelial carcinomas by G-banding, spectral karyotyping and FISH analysis. Int J Cancer. 92:2001;824-831
7. Sokolova I.A., Halling K.C., Jenkins R.B., et al. The development of a multitarget, multicolor fluorescence in situ hybridization assay for the detection of urothelial carcinoma in urine. J Mol Diag. 2:2000;116-123
8. Mostofi F.K., Sobin L.H., Torloni H. Histological typing of urinary bladder tumors. 1973;World Health Organization, Geneva
9. rd ed. 1988;194-195 J. B. Lippincott Co, Philadelphia
10. Halling K.C., King W., Sokolova I.A., et al. A comparison of cytology and fluorescence in situ hybridization for the detection of urothelial carcinoma. J Urol. 164:2000;1768-1775
11. Johnson B., Morales A., Emerson L., Lundie M. Rapid detection of bladder cancer a comparative study of point of care tests. J Urol. 158:1997;2098-2101
12. Neves M., Ciofu C., Larousserie F., et al. Prospective evaluation of genetic abnormalities and telomerase expression in exfoliated urinary cells for bladder detection. J Urol. 167:2002;1276-1281
13. Varella-Garcia M., Gemmill R.M., Rabenhorst S.H., et al. Chromosomal duplication accompanies allelic loss in non-small cell lung carcinoma. Cancer Res. 58:1998;4701-4707
14. Kozubek M., Kozubek S., Lukasova E., et al. High-resolution cytometry of FISH spots in interphase cell nuclei. Cytometry. 36:1999;279-293